Navigation Links
Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast
Date:4/25/2012

RICHMOND, Calif., April 25, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today announced that the company will release its first quarter 2012 financial results on Wednesday, May 2, 2012, after the market closes. The press release will be followed by a conference call at 5:00 p.m. ET, which will be open to the public via telephone and webcast. During the conference call, the company will review the financial results and discuss other business matters.

The conference call dial-in numbers are 877-377-7553 for domestic callers and 678-894-3968 for international callers. The passcode for the call is 73837943. Participants may access the live webcast via a link on the Sangamo BioSciences website in the Investors section under "Events and Presentations," http://investor.sangamo.com/events.cfm. For those unable to listen in at the designated time, a conference call replay will be available for one week following the conference call, from approximately 8:00 p.m. ET on May 2, 2012 to 11:59 p.m. ET on May 9, 2012. The conference call replay numbers for domestic and international callers are 855-859-2056 and 404-537-3406, respectively. The conference ID number for the replay is 73837943.

About Sangamo
Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS. Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia and  hemoglobinopathies such as sickle cell anemia and beta-thalassemia, and a program in Parkinson's disease. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins k
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
2. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
3. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
4. Sangamo BioSciences Announces Presentation at the Lazard Capital Markets 8th Annual Healthcare Conference
5. Sangamo BioSciences Reports Third Quarter 2011 Financial Results
6. Sangamo BioSciences Announces Third Quarter 2011 Conference Call and Webcast
7. Sangamo BioSciences Announces Presentation at the 18th Annual Newsmakers in the Biotech Industry Conference
8. Sangamo BioSciences Announces Presentation at the 2011 UBS Global Life Sciences Conference
9. Sangamo BioSciences Reports Second Quarter 2011 Financial Results
10. Sangamo BioSciences Announces Efficient Generation of Transgenic Pigs Using Zinc Finger Nuclease (ZFN) Technology
11. Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 1, 2015 Goldman Small Cap Research, a ... and microcap sectors, announced today that it has issued ... PMCB), a publicly traded clinical stage biotechnology company focused ... To view the sponsored research article, along with disclosures ... please visit www.GoldmanResearch.com .  In ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Proove ... Personalized Medicine , presented two scientific posters at the ... last week. The four-day event was hosted at the ... specialists dedicated to educating genetic and genomic professionals on ... Genetics and Insomnia: Study on the Role of DAT1 ...
(Date:4/1/2015)... Canada,s Research-Based Pharmaceutical Companies (Rx&D) acknowledges ... on Cost Drivers of Public Drug Plans in ... the rates of change in drug costs have been steadily ... in 2012/13 for a number of select public drug plans. ... of medicines without considering their overall impact on the system ...
(Date:4/1/2015)... and NEW YORK , ... (NASDAQ:  PTBI), a biopharmaceutical company advancing protein biologic ... an overview of the Company,s 2014 achievements and ... below demonstrate the progress the Company has made ... corporate partnerships for its MuGard programs, the FDA ...
Breaking Biology Technology:Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 2Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 3Flurry of Biotech Mergers and Acquisitions Bodes Well for PharmaCyte Biotech 4Proove Biosciences Presents Research Studies at Annual Clinical Genetics Meeting 2015 2Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 2PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 3PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 4PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 5PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements 6
... -- 3SBio Inc.,(Nasdaq: SSRX ), a ... marketing biopharmaceutical products primarily,in China, today announced that ... Financial,Officer, effective February 1, 2009. Since joining 3SBio ... the financial advisor for the company, providing advice,on ...
... Ireland, February 9, Shire plc (LSE: SHP, NASDAQ: ... Notice letters from Barr Laboratories, Inc.,("Barr) and Mylan, Inc. ... each case of the filing of an Abbreviated New ... and 1gm FOSRENOL(R),(lanthanum carbonate). , ...
... Feb. 9 , , ... new Progen board , Call by ... Significant funding shortfall identified in the Progen merger ... Requisition , Late last week Progen Pharmaceuticals Limited (ASX: PGL) responded ...
Cached Biology Technology:3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer 2Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan 2Cytopia and Other Progen Shareholders Maintain Call for Meeting 2Cytopia and Other Progen Shareholders Maintain Call for Meeting 3Cytopia and Other Progen Shareholders Maintain Call for Meeting 4
(Date:4/1/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces the second shipment of ... to early access pre-order customers. Feedback ... outlets including Walmart, Target, AT&T, Dunkin, Donuts, Stop & ... at all outlets and very easy to use. Several ...
(Date:4/1/2015)... --  Medisafe ™, the leading global medication management platform ... and Android smartphones and tablets, announces today ... to allow patients to track and correlate their adherence ... will be able to visualize in real-time how taking ... as glucose levels and blood pressure. "Patients ...
(Date:3/31/2015)... 31, 2015  Elephant Talk Communications Corp. (NYSE MKT: ... of Software Defined Network Architecture (ET Software DNA® 2.0) ... of approximately $20.4 million for the year ended December ... for the year ended December 31, 2013. ... had completed its multi-year transition away from its legacy ...
Breaking Biology News(10 mins):NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... to any process by which a cell converts one ... of signal transduction involve ordered sequences of biochemical reactions ... and activated by second messengers, resulting in a signal ... the order of milliseconds in the case of ion ...
... found the dose of DHA (docosahexaenoic acid) that is "just ... research report appearing in the September 2009 print issue of ... show that a 200 mg dose of DHA per day ... problems, such as those related to aging, atherosclerosis, and diabetes. ...
... Travelers to the neotropicsthe tropical lands of the Americasmight ... insects flittering over sunny puddles or among dense forest ... are moths that have reinvented themselves as butterflies, converging ... hairy relatives. Now, a new revision of the taxonomic ...
Cached Biology News:Moths cloaked in color 2Moths cloaked in color 3Moths cloaked in color 4
...
Convenient 10X buffer concentrate used to maximize binding to the solid phase in microwell ELISA. Formulated to provide optimal pH and ionic strength for binding of antibodies and some antigens. Co...
... making flow cytometry accessible to anyone in the ... latest addition to Guavas on-demand microcapillary flow cytometry ... to use, surprisingly affordable, very compact, and nicely ... The Guava EasyCyte Mini has all of the ...
... systems provide automated, higher throughput screening of ... tubes. This flexible sample format makes the ... basic research, target validation, assay development, and ... the Guava PCA-96 uses a green laser ...
Biology Products: